$2.18 Billion is the total value of Deep Track Capital, LP's 65 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 54.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ISEE | Buy | IVERIC BIO INC | $125,580,000 | +190.1% | 7,000,000 | +55.6% | 5.75% | +102.1% |
| JAZZ | Buy | JAZZ PHARMACEUTICALS PLC | $114,763,000 | +47.1% | 861,000 | +72.2% | 5.26% | +2.5% |
| ASND | New | ASCENDIS PHARMA A/Scall | $103,260,000 | – | 1,000,000 | +100.0% | 4.73% | – |
| TVTX | Buy | TRAVERE THERAPEUTICS INC | $98,560,000 | +13.6% | 4,000,000 | +11.7% | 4.51% | -20.8% |
| NVCR | Sell | NOVOCURE LTD | $98,300,000 | +5.4% | 1,293,761 | -3.5% | 4.50% | -26.5% |
| HZNP | New | HORIZON THERAPEUTICS PUB L | $90,533,000 | – | 1,462,800 | +100.0% | 4.15% | – |
| ASND | New | ASCENDIS PHARMA A/Ssponsored adr | $82,608,000 | – | 800,000 | +100.0% | 3.78% | – |
| SWTX | New | SPRINGWORKS THERAPEUTICS INC | $67,594,000 | – | 2,369,210 | +100.0% | 3.10% | – |
| BCYC | BICYCLE THERAPEUTICS PLCsponsored ads | $67,454,000 | +38.6% | 2,900,000 | 0.0% | 3.09% | -3.4% | |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $62,633,000 | +15.5% | 738,863 | +12.9% | 2.87% | -19.6% |
| KDNY | Sell | CHINOOK THERAPEUTICS INC | $58,980,000 | -1.7% | 3,000,000 | -12.5% | 2.70% | -31.5% |
| IMVT | Buy | IMMUNOVANT INC | $55,020,000 | +49.2% | 9,860,246 | +4.3% | 2.52% | +4.0% |
| AGEN | Buy | AGENUS INC | $53,966,000 | +25.1% | 26,325,000 | +18.4% | 2.47% | -12.9% |
| BEAM | Sell | BEAM THERAPEUTICS INC | $47,640,000 | -1.5% | 1,000,000 | -20.0% | 2.18% | -31.4% |
| KURA | Sell | KURA ONCOLOGY INC | $43,522,000 | -35.8% | 3,186,083 | -13.8% | 1.99% | -55.3% |
| AUPH | New | AURINIA PHARMACEUTICALS INC | $42,694,000 | – | 5,677,372 | +100.0% | 1.96% | – |
| DYN | Sell | DYNE THERAPEUTICS INC | $40,439,000 | +68.2% | 3,184,200 | -9.0% | 1.85% | +17.1% |
| VRDN | Buy | VIRIDIAN THERAPEUTICS INC | $40,411,000 | +198.5% | 1,970,290 | +68.4% | 1.85% | +108.0% |
| RPTX | Buy | REPARE THERAPEUTICS INC | $37,939,000 | +0.2% | 3,127,667 | +15.5% | 1.74% | -30.2% |
| ABOS | Buy | ACUMEN PHARMACEUTICALS INC | $37,902,000 | +160.1% | 3,778,818 | +21.9% | 1.74% | +81.2% |
| ESPR | Sell | ESPERION THERAPEUTICS INC NE | $37,765,000 | -1.0% | 5,636,587 | -6.1% | 1.73% | -31.0% |
| NKTX | NKARTA INC | $37,043,000 | +6.8% | 2,814,844 | 0.0% | 1.70% | -25.6% | |
| HRTX | New | HERON THERAPEUTICS INC | $36,074,000 | – | 8,548,387 | +100.0% | 1.65% | – |
| ISEE | New | IVERIC BIO INCcall | $35,880,000 | – | 2,000,000 | +100.0% | 1.64% | – |
| EWTX | New | EDGEWISE THERAPEUTICS INC | $33,204,000 | – | 3,374,394 | +100.0% | 1.52% | – |
| FATE | Sell | FATE THERAPEUTICS INC | $29,382,000 | -41.2% | 1,311,113 | -35.0% | 1.35% | -59.1% |
| PLRX | New | PLIANT THERAPEUTICS INC | $29,241,000 | – | 1,399,744 | +100.0% | 1.34% | – |
| VRNA | New | VERONA PHARMA PLCsponsored ads | $28,913,000 | – | 2,829,094 | +100.0% | 1.32% | – |
| ALLK | New | ALLAKOS INC | $27,654,000 | – | 4,518,575 | +100.0% | 1.27% | – |
| AKRO | New | AKERO THERAPEUTICS INC | $26,931,000 | – | 790,926 | +100.0% | 1.23% | – |
| NRIX | Sell | NURIX THERAPEUTICS INC | $26,759,000 | -13.3% | 2,053,621 | -15.7% | 1.22% | -39.6% |
| VERV | New | VERVE THERAPEUTICS INC | $26,621,000 | – | 775,000 | +100.0% | 1.22% | – |
| KALV | KALVISTA PHARMACEUTICALS INC | $26,466,000 | +47.5% | 1,824,000 | 0.0% | 1.21% | +2.7% | |
| FDMT | Buy | 4D MOLECULAR THERAPEUTICS IN | $25,701,000 | +17.3% | 3,196,642 | +1.8% | 1.18% | -18.3% |
| New | THIRD HARMONIC BIO INC | $24,058,000 | – | 1,268,220 | +100.0% | 1.10% | – | |
| GBT | Sell | GLOBAL BLOOD THERAPEUTICS IN | $22,241,000 | -80.9% | 326,600 | -91.0% | 1.02% | -86.7% |
| ALBO | New | ALBIREO PHARMA INC | $21,502,000 | – | 1,110,624 | +100.0% | 0.98% | – |
| Buy | VIGIL NEUROSCIENCE INC | $21,505,000 | +2601.6% | 2,363,188 | +666.3% | 0.98% | +1794.2% | |
| NUVB | Sell | NUVATION BIO INC | $20,889,000 | -43.8% | 9,325,540 | -18.7% | 0.96% | -60.8% |
| CRNX | CRINETICS PHARMACEUTICALS IN | $20,681,000 | +5.3% | 1,053,000 | 0.0% | 0.95% | -26.6% | |
| Sell | DICE THERAPEUTICS INC | $20,280,000 | +25.3% | 1,000,000 | -4.1% | 0.93% | -12.7% | |
| SLN | Buy | SILENCE THERAPEUTICS PLCads | $19,584,000 | +73.7% | 1,951,580 | +105.1% | 0.90% | +21.1% |
| FMTX | Sell | FORMA THERAPEUTICS HLDGS INC | $19,283,000 | -30.9% | 966,573 | -76.1% | 0.88% | -51.9% |
| ARDX | New | ARDELYX INC | $17,681,000 | – | 14,858,000 | +100.0% | 0.81% | – |
| RLMD | Sell | RELMADA THERAPEUTICS INC | $17,061,000 | +79.7% | 460,861 | -7.8% | 0.78% | +25.2% |
| NTLA | New | INTELLIA THERAPEUTICS INC | $16,788,000 | – | 300,000 | +100.0% | 0.77% | – |
| ETNB | New | 89BIO INC | $15,262,000 | – | 2,636,000 | +100.0% | 0.70% | – |
| TCDA | Sell | TRICIDA INC | $12,342,000 | -53.3% | 1,177,680 | -56.9% | 0.56% | -67.5% |
| ACET | Sell | ADICET BIO INC | $11,739,000 | -9.9% | 825,508 | -7.5% | 0.54% | -37.1% |
| JNCE | JOUNCE THERAPEUTICS INC | $9,968,000 | -22.8% | 4,259,653 | 0.0% | 0.46% | -46.1% | |
| KROS | Sell | KEROS THERAPEUTICS INC | $9,349,000 | -54.2% | 248,500 | -66.4% | 0.43% | -68.1% |
| ANAB | Sell | ANAPTYSBIO INC | $9,184,000 | -32.7% | 360,000 | -46.5% | 0.42% | -53.1% |
| IPSC | CENTURY THERAPEUTICS INC | $9,145,000 | +17.7% | 924,641 | 0.0% | 0.42% | -18.0% | |
| INZY | INOZYME PHARMA INC | $8,710,000 | -43.8% | 3,250,000 | 0.0% | 0.40% | -60.8% | |
| TCDA | New | TRICIDA INCcall | $8,098,000 | – | 772,700 | +100.0% | 0.37% | – |
| RETA | New | REATA PHARMACEUTICALS INCput | $7,961,000 | – | 316,800 | +100.0% | 0.36% | – |
| MGTA | MAGENTA THERAPEUTICS INC | $7,556,000 | +17.5% | 5,359,000 | 0.0% | 0.35% | -18.2% | |
| FULC | Sell | FULCRUM THERAPEUTICS INC | $7,287,000 | +48.7% | 900,711 | -9.9% | 0.33% | +3.7% |
| HOOK | HOOKIPA PHARMA INC | $6,748,000 | -17.8% | 5,035,998 | 0.0% | 0.31% | -42.8% | |
| GHRS | GH RESEARCH PLCordinary shares | $5,803,000 | +16.4% | 499,400 | 0.0% | 0.27% | -18.9% | |
| ASMB | ASSEMBLY BIOSCIENCES INC | $4,920,000 | -21.9% | 3,000,000 | 0.0% | 0.22% | -45.7% | |
| RLMD | New | RELMADA THERAPEUTICS INCcall | $4,339,000 | – | 117,200 | +100.0% | 0.20% | – |
| SDGR | Sell | SCHRODINGER INC | $4,247,000 | -71.4% | 170,000 | -69.8% | 0.19% | -80.1% |
| PASG | Sell | PASSAGE BIO INC | $1,799,000 | -67.1% | 1,439,062 | -38.0% | 0.08% | -77.2% |
| GRTS | Sell | GRITSTONE BIO INC | $117,000 | -97.2% | 45,500 | -97.4% | 0.01% | -98.2% |
| LIFE | Exit | ATYR PHARMA INC | $0 | – | -290,844 | -100.0% | -0.05% | – |
| PTGX | Exit | PROTAGONIST THERAPEUTICS INCput | $0 | – | -260,500 | -100.0% | -0.14% | – |
| Exit | TENAYA THERAPEUTICS INC | $0 | – | -483,836 | -100.0% | -0.18% | – | |
| SAGE | Exit | SAGE THERAPEUTICS INC | $0 | – | -171,800 | -100.0% | -0.36% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS INC | $0 | – | -1,733,130 | -100.0% | -1.60% | – |
| MDGL | Exit | MADRIGAL PHARMACEUTICALS INC | $0 | – | -905,000 | -100.0% | -4.26% | – |
| ALNY | Exit | ALNYLAM PHARMACEUTICALS INCcall | $0 | – | -499,900 | -100.0% | -4.79% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| JAZZ PHARMACEUTICALS PLC | 8 | Q3 2023 | 7.2% |
| TRAVERE THERAPEUTICS INC | 8 | Q3 2023 | 5.7% |
| IMMUNOVANT INC | 8 | Q3 2023 | 7.2% |
| BICYCLE THERAPEUTICS PLC | 8 | Q3 2023 | 5.2% |
| BEAM THERAPEUTICS INC | 8 | Q3 2023 | 3.9% |
| 4D MOLECULAR THERAPEUTICS IN | 8 | Q3 2023 | 2.9% |
| REPARE THERAPEUTICS INC | 8 | Q3 2023 | 3.1% |
| VIRIDIAN THERAPEUTICS INC | 8 | Q3 2023 | 2.2% |
| DYNE THERAPEUTICS INC | 8 | Q3 2023 | 2.2% |
| SILENCE THERAPEUTICS PLC | 8 | Q3 2023 | 1.6% |
View Deep Track Capital, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Orchard Therapeutics plc | March 20, 2023 | 19,125,150 | 10.0% |
| ARDELYX, INC.Sold out | February 14, 2023 | 0 | 0.0% |
| ASSEMBLY BIOSCIENCES, INC. | February 14, 2023 | 1,833,437 | 3.8% |
| Aurinia Pharmaceuticals Inc. | February 14, 2023 | 324,238 | 0.2% |
| CHINOOK THERAPEUTICS, INC. | February 14, 2023 | 3,000,000 | 4.7% |
| Forma Therapeutics Holdings, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Global Blood Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| HOOKIPA Pharma Inc. | February 14, 2023 | 1,240,369 | 2.4% |
| KalVista Pharmaceuticals, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Keros Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
View Deep Track Capital, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-04-26 |
| SC 13G | 2024-04-26 |
| SC 13G/A | 2024-04-22 |
| SC 13G | 2024-04-12 |
| SC 13G | 2024-04-05 |
| SC 13G | 2024-03-22 |
| SC 13G | 2024-03-22 |
| SC 13G | 2024-03-22 |
| SC 13G | 2024-03-15 |
| 3 | 2024-03-14 |
View Deep Track Capital, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.